Resource centre

Bibliography
News & insights
Whitepapers, publications & posters
Upcoming events & webinars
Webinar recordings

News & insights
19 November 2024
Exploring Innovation in Alzheimer's Disease Research: Highlights from CTAD 2024
Read more
01 November 2024
CTAD24 | Posters & Content
Read more
01 November 2024
Shaping the Future of Patient-Centric, AI-Driven Research
Read more
29 October 2024
CTAD24 | Clinical Trials on Alzheimer's Disease
Read more
18 October 2024
Clinical Trials Innovation Summit 2024
Read more
24 September 2024
2023 CANTAB Research Grant Winner: Assessment of cognitive function in patients of breast cancer on chemotherapy: A prospective longitudinal study at tertiary care centre in India
Read more
14 September 2024
ISCTM 2024: Analytical validation of a novel quality assurance approach for COAs in Alzheimer’s Disease clinical trials
Read more
10 July 2024
Cambridge Cognition secures Innovate UK grant to collect multimodal data with a large patient sample in the Bio-Hermes-002 project
Read more
16 May 2024
New partnership with the University of Essex to strengthen CANTAB® normative data offering
Read more
30 April 2024
Cambridge Cognition and The Michael J. Fox Foundation to employ digital cognitive assessments in unraveling the mysteries of Parkinson’s disease
Read more
29 April 2024
Supporting research into central nervous system (CNS) disorders to improve patient quality of life
Read more
23 April 2024
Cambridge Cognition spin-out Monument Therapeutics accesses £1.5m for schizophrenia clinical development
Read more
16 April 2024
2023 CANTAB Research Grant: Exploring the role of intermittent exogenous ketosis on physical and mental fatigue during ultra-endurance performance
Read more
10 April 2024
Cambridge Cognition strengthens senior management team to deliver growth
Read more
03 April 2024
2023 CANTAB Research Grant: The microbiota-gut-brain axis in young binge drinkers: The interplay between alcohol use, microbiota composition and neurocognitive functioning
Read more
21 March 2024
Cambridge Cognition announces scientific advisory board
Read more
22 February 2024
Digital Biomarkers & Alzheimer’s Research: Q&A with Liam Kaufman, VP of Clinical Sciences
Read more
20 February 2024
Cambridge Cognition and ActiGraph announce partnership to accelerate central nervous system trials
Read more
13 February 2024
Cambridge Cognition's Global Teams Unite for Mental Health Causes! 
Read more
07 December 2023
Technology for successful decentralised clinical trials
Read more
Find more of our insights

Whitepapers, publications & posters
19 November 2024
Exploring Innovation in Alzheimer's Disease Research: Highlights from CTAD 2024
01 November 2024
CTAD24 | Posters & Content
29 October 2024
CTAD24 | Clinical Trials on Alzheimer's Disease
18 October 2024
Clinical Trials Innovation Summit 2024
14 September 2024
ISCTM 2024: Analytical validation of a novel quality assurance approach for COAs in Alzheimer’s Disease clinical trials
05 March 2024
Digital measures to advance research & quality of life in schizophrenia
01 March 2024
Prediction of mental effort derived from an automated vocal biomarker using machine learning in a large-scale remote sample
22 June 2023
Evaluating the utility of daily speech assessments for monitoring depression symptoms
25 May 2023
Frontiers in Neurology | Revolutionising the detection of cognitive impairment in multiple sclerosis with technology
25 May 2023
Frontiers in Psychiatry | Using affective cognition to enhance precision psychiatry
25 May 2023
CANTAB Mobile: experience of use of a digital memory screening tool in primary care
28 November 2017
Neuroscience & Biobehavioral Reviews | Social cognition: an important but overlooked aspect of cognitive function

eBooks & whitepapers

Upcoming events

Find more events

Webinar recordings
26 October 2023
Success Factors for Remote and Hybrid Decentralised Trials from Site, Technology and Service Provider Perspectives with a Focus on the RADIAL Study from Trials@Home
31 May 2023
Monitoring fluctuations in psychiatric symptoms though analysis of speech
31 May 2023
Speech analytics and natural language processing for automation of quality assurance in clinical trials
31 May 2023
Speech biomarkers from active and passive collection of voice in Alzhiemer’s disease clinical trials
29 September 2022
Real-World Measurement of Cognition and Mood in Frontline COVID-19 Healthcare Workers
12 April 2022
Successful Statistical Strategies for Patient Screening and Stratification
11 November 2021
Decentralised Trials in Psychiatry: From Feasibility to Novel Insights
29 October 2021
Novel Digital Technologies and Biomarkers to Characterise Depression
21 October 2021
Digital Health Event 2021: Integrating multimodal data to meet clinical challenges
07 July 2021
Voice Technology in Clinical Trials
16 October 2020
Virtual clinical trials: What have we learned in the era of Covid-19?
29 September 2020
Remote Cognitive Testing and Lessons Learned During Lockdown
18 September 2020
Wearable Technology for High-Frequency Cognitive and Mood Assessments in Depression
01 June 2020
Elderly patients in clinical trials: addressing the evidence-practice gap
12 February 2020
Future directions in eCOA: Innovations in high-frequency and automated voice-based testing
02 January 2020
Pro-cognitive drug trial failures in schizophrenia: the need for cognitive screening?
07 June 2019
Cognitive Safety: Satisfying Regulatory Requirements in a Competitive Landscape
24 October 2018
Digital Health: Optimizing Clinical Trials with Patient-Centric Technology
25 May 2018
Early Alzheimer’s Disease: Finding the Right Patients for Clinical Trials and Beyond
06 February 2018
Schizophrenia Trials: Overcoming Methodological Challenges to Enhance Study Success
23 March 2017
Leveraging Cognitive Measures in Clinical Trials
23 March 2017
Understanding the Clinical Assessment of Abuse Potential during CNS Drug Development
23 March 2017
Assessing Cognitive Safety of Drugs in Clinical Development
Cambridge Cognition
Scroll to Top